Mojgan Rahimi

Mojgan Rahimi

Auto-generated profile, based on publicly available information

Mojgan Rahimi

Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
PMParsa Mohammadi
Parsa Mohammadi
HVHesam Varpaei
Hesam Varpaei
AKAlireza Khafaee pour Khamseh
Alireza Khafaee pour Khamseh
MMMostafa Mohammadi
Mostafa Mohammadi
MRMojgan Rahimi
Mojgan Rahimi
AOAmirhossein Orandi
Amirhossein Orandi
Background. Malnutrition in COVID-19 critically ill patients can lead to poor prognosis. This study aimed to evaluate the association between nutritional status (or risk) and the prognosis of critically ill COVID-19 patients. In this study, prognosis is the primary outcome of “hospital mortality” patients. The second outcome is defined as “need for mechanical ventilation.” Methods and Materials. In this single-center prospective cohort study, 110 patients admitted to the Intensive Care Unit of Imam Khomeini Hospital Complex (Tehran, Iran) between April and September 2021 were enrolled. Participants formed a consecutive sample. MNA-SF, NRS-2002, mNUTRIC, and PNI scores were used to evaluate nutritional assessment. Patients’ lab results and pulse oximetric saturation SpO2/FiO2 (SF) ratio at the time of intensive care unit (ICU) admission were collected. Patients were screened for nutritional status and categorized into two groups, patients at nutritional risk and nonrisk. Results. Sixty-five (59.1%) of all patients were men. The overall range of age was 52 ± 15. Thirty-six (32.7%) of patients were obese (BMI ≥ 30). The hospital mortality rate was 59.1% (n = 65). According to the different criteria, malnutrition rate was 67.3% (n = 74) (NRS), 28.2% (n = 31) (MNA), 34.5% (n = 38) (mNUTRIC), and 58.2% (n = 64) (PNI). There was a statistically significant association between chronic kidney disease (CKD) and mNUTRIC risk (OR = 13.5, 95% CI (1.89–16.05), ), diabetes mellitus (DM) and MNA risk (OR = 2.82, 95% CI (1.01–7.83), ), hypertension (HTN) and MNA risk (OR = 5.63, 95% CI (2.26–14.05), ), and malignancy and mNUTRIC risk ( ). The nutritional risk (all tools) significantly increased the odds of in-hospital death and need for mechanical ventilation. The length of stay was not significantly different in malnourished patients. Conclusion. In the critical care setting of COVID-19 patients, malnutrition is prevalent. Malnutrition (nutritional risk) is associated with an increased risk of need for mechanical ventilation and in-hospital mortality. Patients with a history of HTN, CKD, DM, and cancer are more likely to be at nutritional risk at the time of ICU admission.

30 April 2026 in Archives of Neuroscience
Verified
Journal Article
Open access
PDF file
MRMojgan Rahimi
Mojgan Rahimi
AFAmirhossein Farhadi
Amirhossein Farhadi
RAReza Effatdoost Astane
Reza Effatdoost Astane
BEBabak Eslami
Babak Eslami
AMAlireza Montaseri
Alireza Montaseri
Background: Sodium thiopental is commonly used for the induction of general anesthesia; however, selecting an appropriate weight descriptor for dosing in patients with BMI > 25 kg/m2 remains challenging because excess body weight and associated physiologic changes may affect anesthetic depth and dosing requirements. Objectives: To compare the effectiveness and safety of using total body weight, ideal body weight, and adjusted body weight to calculate sodium thiopental induction doses in adults with BMI > 25 kg/m2, using the bispectral index (BIS) as the primary measure of anesthetic depth and using hemodynamic responses and supplemental thiopental requirements as secondary outcomes. Methods: In this single-center randomized clinical trial, 91 adults with a body mass index greater than 25 kg/m2 were allocated to receive sodium thiopental at 5 mg/kg, calculated using total body weight, ideal body weight, or adjusted body weight. The bispectral index, heart rate, and mean arterial pressure were recorded at baseline, 1 minute after completion of the initial sodium thiopental injection, and 3 minutes after tracheal intubation. The primary outcome was the bispectral index 1 minute after completion of the initial thiopental dose. Secondary outcomes included heart rate, mean arterial pressure, total thiopental dose, and the need for supplemental thiopental boluses. Results: After the initial dose, the bispectral index differed significantly among groups (P < 0.001), with higher values in the ideal body weight group (59.81 ± 14.2) than in the total body weight group (38.75 ± 12.66) and the adjusted body weight group (44.21 ± 12.53). The mean total thiopental dose was 427.25 ± 44.17 mg in the total body weight group, 433.75 ± 125.25 mg in the ideal body weight group, and 371.93 ± 69.96 mg in the adjusted body weight group. Supplemental thiopental boluses were required in 3.3% of patients in the total body weight group, 24.1% in the adjusted body weight group, and 78.1% in the ideal body weight group; 15.6% of patients in the ideal body weight group did not achieve a BIS < 50 despite receiving a total thiopental dose of 500 mg. After intubation, the mean arterial pressure was highest in the adjusted body weight group (117.76 ± 16.98 mm Hg; P = 0.035), whereas the heart rate did not differ significantly among groups. Conclusions: Overall, adjusted body weight dosing appeared to provide a more dose-efficient induction profile, achieving clinically acceptable anesthetic depth with a lower total thiopental requirement than total body weight dosing while maintaining broadly comparable hemodynamic responses. In contrast, ideal body weight dosing at 5 mg/kg appeared less reliable in this population, as reflected by the markedly higher need for supplemental thiopental boluses and occasional failure to achieve the target bispectral index threshold. These findings support the concept that an intermediate weight descriptor may better balance the competing risks of excessive hypnotic depth with total body weight dosing and insufficient hypnotic depth with ideal body weight dosing in patients with BMI > 25 kg/m2. Adjusted body weight dosing appeared to provide a more dose-efficient induction strategy than total body weight dosing while avoiding the frequent requirement for supplemental thiopental boluses observed with ideal body weight dosing. Ideal body weight dosing at 5 mg/kg appeared less reliable in adults with BMI > 25 kg/m2 under the conditions of this study.